Close

vTv Therapeutics (VTVT) Announces Presentation of Phase 2b Azeliragon Results at AAIC

July 27, 2016 5:23 PM EDT Send to a Friend
vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login